Patent · US Active

Formulations of 6-mercaptopurine

US8188067B2 · kind B2 · utility

6Cited by
29References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 1, 2005
Grant dateMay 29, 2012
Priority date
Expiry dateAug 10, 2027

Classification

  • Technology area (CPC B)Performing Operations; Transporting
  • CPC primaryB01J2/16
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides improved formulations of 6-mercaptopurine that exhibit better bioavailability and faster dissolution than previous formulations.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.